Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Enveric Biosciences Canada Inc.”

22 pharma patents match "Enveric Biosciences Canada Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 22
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 22 pharmaceutical patents matching "Enveric Biosciences Canada Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

22 results for “Enveric Biosciences Canada Inc.” · 30,257 patents in full index Clear search

  1. US 12428408

    Fused heterocyclic mescaline derivatives

    Enveric Biosciences Canada Inc. · Granted Sep 30, 2025 · Expires Sep 25, 2045

    granted
  2. US 12378195

    Aminated psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  3. US 12358885

    Substituted n-propylamine fused heterocyclic mescaline derivatives

    Enveric Biosciences Canada Inc. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  4. US 12338231

    N-heterocycle substituted tryptamine derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Jun 24, 2025 · Expires Jun 19, 2045

    granted
  5. US 12195439

    C1-substituted isopropylamine fused heterocyclic mescaline derivatives

    Enveric Biosciences Canada Inc. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  6. US 12187679

    Hydroxylated psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  7. US 12138276

    Halogenated psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Nov 12, 2024 · Expires Nov 7, 2044

    granted
  8. US 12133856

    Multi-substituent psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Nov 5, 2024 · Expires Oct 31, 2044

    granted
  9. US 12128058

    Multi-substituent psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Oct 29, 2024 · Expires Oct 24, 2044

    granted
  10. US 12077498

    C4-carboxylic acid-substituted tryptamine derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted
  11. US 12065404

    C4-carboxylic acid-substituted tryptamine derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  12. US 11998557

    Halogenated psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  13. US 11945778

    C4-carbonothioate-substituted tryptamine derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Apr 2, 2024 · Expires Mar 28, 2044

    granted
  14. US 11931338

    Nitrilated psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  15. US 11918594

    Multi-substituent psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  16. US 11891360

    Glycosylated psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Feb 6, 2024 · Expires Feb 1, 2044

    granted
  17. US 11858895

    Aminated psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  18. US 11845726

    C4-carbonothioate-substituted tryptamine derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Dec 19, 2023 · Expires Dec 14, 2043

    granted
  19. US 11845727

    Aldehyde and ketone derivatives of psilocybin and methods of using

    Enveric Biosciences Canada Inc. · Granted Dec 19, 2023 · Expires Dec 14, 2043

    granted
  20. US 11752130

    Carboxylated psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  21. US 11746087

    C4-carboxylic acid-substituted tryptamine derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted
  22. US 11707447

    C4-carbonothioate-substituted tryptamine derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted